Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Choose Topic

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Journal of the National Cancer Institute | Nov 07, 2017 General Oncology Neurologic Oncology

Safety, pharmacokinetics and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Neuro-Oncology | Nov 07, 2017 Neurologic Oncology Pharmacology/Therapy General Oncology

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

Journal of Hematology & Oncology | Nov 07, 2017 Leukemia/Lymphoma General Oncology

Long-term outcomes of endoscopic submucosal dissection vs surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: A criteria-based analysis

Gastric Cancer | Nov 07, 2017 General Oncology GI Oncology

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

Pediatric Blood & Cancer | Nov 07, 2017 Neurologic Oncology Peds Heme/Oncology General Oncology

Adjuvant therapy use and survival in stage II endometrial cancer

International Journal of Gynecological Cancer | Nov 07, 2017 General Oncology Gynecologic Oncology

Randomized phase II study of R-CHOP with or without bortezomib in previously untreated patients with nonâgerminal center B-cellâlike diffuse large B-cell lymphoma

Journal of Clinical Oncology | Nov 06, 2017 Leukemia/Lymphoma General Oncology

Safety of fertility preservation in breast cancer patients in a register-based matched cohort study

Breast Cancer Research and Treatment | Nov 06, 2017 Breast General Oncology

Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: A multi-institutional retrospective analysis of KROG 16-01

Gynecologic Oncology | Nov 06, 2017 Gynecologic Oncology Diagnostics/Radiology General Oncology

Combination of α-blocker and 5α-reductase inhibitor for treatment of benign prostatic hyperplasia

Clinical and Investigative Medicine | Nov 06, 2017 Renal/Urologic General Oncology

« Prev 1 … 1140 1141 1142 1143 1144 … 1255 Next »

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Safety, pharmacokinetics and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

Long-term outcomes of endoscopic submucosal dissection vs surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: A criteria-based analysis

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

Adjuvant therapy use and survival in stage II endometrial cancer

Randomized phase II study of R-CHOP with or without bortezomib in previously untreated patients with nonâgerminal center B-cellâlike diffuse large B-cell lymphoma

Safety of fertility preservation in breast cancer patients in a register-based matched cohort study

Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: A multi-institutional retrospective analysis of KROG 16-01

Combination of α-blocker and 5α-reductase inhibitor for treatment of benign prostatic hyperplasia

10 Common Household Products Driving Early Puberty

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Thyroid Disorders and Management in Pregnancy

Oral Microbiota in the Human System and Diseases

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Safety, pharmacokinetics and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

Long-term outcomes of endoscopic submucosal dissection vs surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: A criteria-based analysis

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

Adjuvant therapy use and survival in stage II endometrial cancer

Randomized phase II study of R-CHOP with or without bortezomib in previously untreated patients with nonâgerminal center B-cellâlike diffuse large B-cell lymphoma

Safety of fertility preservation in breast cancer patients in a register-based matched cohort study

Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: A multi-institutional retrospective analysis of KROG 16-01

Combination of α-blocker and 5α-reductase inhibitor for treatment of benign prostatic hyperplasia

10 Common Household Products Driving Early Puberty

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Thyroid Disorders and Management in Pregnancy

Oral Microbiota in the Human System and Diseases

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Select Specialty

Select Topic

Randomized phase II study of R-CHOP with or without bortezomib in previously untreated patients with nonâgerminal center B-cellâlike diffuse large B-cell lymphoma